References
Awini, E.A., Bonney, J.H.K., Frimpong,
J.A., Ampofo, W.K., Koram, K.A., 2017. Information gaps in surveillance
data and effects on the Ghanaian response to the Ebola outbreak in West
Africa. Ghana medical journal 51, 115-119.
Baize, S., Pannetier, D., Oestereich,
L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M.S.,
Keita, S., De Clerck, H., Tiffany, A., Dominguez, G., Loua, M., Traore,
A., Kolie, M., Malano, E.R., Heleze, E., Bocquin, A., Mely, S., Raoul,
H., Caro, V., Cadar, D., Gabriel, M., Pahlmann, M., Tappe, D.,
Schmidt-Chanasit, J., Impouma, B., Diallo, A.K., Formenty, P., Van Herp,
M., Gunther, S., 2014. Emergence of Zaire Ebola virus disease in Guinea.
N Engl J Med 371, 1418-1425.
Cantoni, D., Rossman, J.S., 2018.
Ebolaviruses: New roles for old proteins. PLoS Negl Trop Dis 12,
e0006349.
Chen, Q., Tang, K., Zhang, X., Chen,
P., Guo, Y., 2018. Establishment of pseudovirus infection mouse models
for in vivo pharmacodynamics evaluation of filovirus entry inhibitors.
Acta pharmaceutica Sinica. B 8, 200-208.
Cheresiz, S.V., Kononova, A.A.,
Razumova, Y.V., Dubich, T.S., Chepurnov, A.A., Kushch, A.A., Davey, R.,
Pokrovsky, A.G., 2014. A vesicular stomatitis pseudovirus expressing the
surface glycoproteins of influenza A virus. Archives of Virology 159,
2651-2658.
Gire, S.K., Goba, A., Andersen, K.G.,
Sealfon, R.S., Park, D.J., Kanneh, L., Jalloh, S., Momoh, M., Fullah,
M., Dudas, G., Wohl, S., Moses, L.M., Yozwiak, N.L., Winnicki, S.,
Matranga, C.B., Malboeuf, C.M., Qu, J., Gladden, A.D., Schaffner, S.F.,
Yang, X., Jiang, P.P., Nekoui, M., Colubri, A., Coomber, M.R., Fonnie,
M., Moigboi, A., Gbakie, M., Kamara, F.K., Tucker, V., Konuwa, E.,
Saffa, S., Sellu, J., Jalloh, A.A., Kovoma, A., Koninga, J., Mustapha,
I., Kargbo, K., Foday, M., Yillah, M., Kanneh, F., Robert, W., Massally,
J.L., Chapman, S.B., Bochicchio, J., Murphy, C., Nusbaum, C., Young, S.,
Birren, B.W., Grant, D.S., Scheiffelin, J.S., Lander, E.S., Happi, C.,
Gevao, S.M., Gnirke, A., Rambaut, A., Garry, R.F., Khan, S.H., Sabeti,
P.C., 2014. Genomic surveillance elucidates Ebola virus origin and
transmission during the 2014 outbreak. Science 345, 1369-1372.
Harrod, K.S., 2015. Ebola: history,
treatment, and lessons from a new emerging pathogen. Am J Physiol Lung
Cell Mol Physiol 308, L307-313.
Konduru, K., Shurtleff, A.C., Bavari,
S., Kaplan, G., 2018. High degree of correlation between Ebola virus
BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence
reduction neutralization test. J Virol Methods 254, 1-7.
Lee, J.E., Fusco, M.L., Hessell, A.J.,
Oswald, W.B., Burton, D.R., Saphire, E.O., 2008. Structure of the Ebola
virus glycoprotein bound to an antibody from a human survivor. Nature
454, 177-182.
Lee, S.S., Phy, K., Peden, K.,
Sheng-Fowler, L., 2017. Development of a micro-neutralization assay for
ebolaviruses using a replication-competent vesicular stomatitis hybrid
virus and a quantitative PCR readout. Vaccine 35, 5481-5486.
Lennemann, N.J., Herbert, A.S.,
Brouillette, R., Rhein, B., Bakken, R.A., Perschbacher, K.J., Cooney,
A.L., Miller-Hunt, C.L., Ten Eyck, P., Biggins, J., Olinger, G., Dye,
J.M., Maury, W., 2017. Vesicular Stomatitis Virus Pseudotyped with Ebola
Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against
Ebola Virus Challenge in Mice. Journal of Virology 91.
Maruyama, T., Rodriguez, L.L.,
Jahrling, P.B., Sanchez, A., Khan, A.S., Nichol, S.T., Peters, C.J.,
Parren, P.W., Burton, D.R., 1999. Ebola virus can be effectively
neutralized by antibody produced in natural human infection. J Virol 73,
6024-6030.
Mbala Kingebeni, P.,
Villabona-Arenas, C.J., Vidal, N., Likofata, J., Nsio-Mbeta, J.,
Makiala-Mandanda, S., Mukadi, D., Mukadi, P., Kumakamba, C., Djokolo,
B., Ayouba, A., Delaporte, E., Peeters, M., Muyembe Tamfum, J.J., Ahuka
Mundeke, S., 2018. Rapid confirmation of the Zaire Ebola Virus in the
outbreak of the Equateur province in the Democratic Republic of Congo:
implications for public health interventions. Clin Infect Dis.
Mohan, G.S., Li, W., Ye, L., Compans,
R.W., Yang, C., 2012. Antigenic subversion: a novel mechanism of host
immune evasion by Ebola virus. PLoS Pathog 8, e1003065.
Nkengasong, J.N., Onyebujoh, P.,
2018. Response to the Ebola virus disease outbreak in the Democratic
Republic of the Congo. Lancet 391, 2395-2398.
Panina, A.A., Dementieva, I.G.,
Aliev, T.K., Toporova, V.A., Balabashin, D.S., Bokov, M.N., Pozdnyakova,
L.P., Shchemchukova, O.B., Dolgikh, D.A., Sveshnikov, P.G.,
Kirpichnikov, M.P., 2017. Recombinant Antibodies to the Ebola Virus
Glycoprotein. Acta Naturae 9, 84-91.
Qiu, C., Huang, Y., Zhang, A., Tian,
D., Wan, Y., Zhang, X., Zhang, W., Zhang, Z., Yuan, Z., Hu, Y., 2013.
Safe Pseudovirus-based Assay for Neutralization Antibodies against
Influenza A(H7N9) Virus. Emerging Infectious Diseases 19, 1685-1687.
Qiu, X., Wong, G., Audet, J., Bello,
A., Fernando, L., Alimonti, J.B., Fausther-Bovendo, H., Wei, H., Aviles,
J., Hiatt, E., Johnson, A., Morton, J., Swope, K., Bohorov, O.,
Bohorova, N., Goodman, C., Kim, D., Pauly, M.H., Velasco, J., Pettitt,
J., Olinger, G.G., Whaley, K., Xu, B., Strong, J.E., Zeitlin, L.,
Kobinger, G.P., 2014. Reversion of advanced Ebola virus disease in
nonhuman primates with ZMapp. Nature 514, 47-53.
Shrivastava-Ranjan, P., Flint, M.,
Bergeron, E., McElroy, A.K., Chatterjee, P., Albarino, C.G., Nichol,
S.T., Spiropoulou, C.F., 2018. Statins Suppress Ebola Virus Infectivity
by Interfering with Glycoprotein Processing. mBio 9.
Subissi, L., Keita, M., Mesfin, S.,
Rezza, G., Diallo, B., Van Gucht, S., Musa, E.O., Yoti, Z., Keita, S.,
Djingarey, M.H., Diallo, A.B., Fall, I.S., 2018. Ebola Virus
Transmission Caused by Persistently Infected Survivors of the 2014-2016
Outbreak in West Africa. J Infect Dis.
Sullivan, N.J., Hensley, L., Asiedu,
C., Geisbert, T.W., Stanley, D., Johnson, J., Honko, A., Olinger, G.,
Bailey, M., Geisbert, J.B., Reimann, K.A., Bao, S., Rao, S., Roederer,
M., Jahrling, P.B., Koup, R.A., Nabel, G.J., 2011. CD8+ cellular
immunity mediates rAd5 vaccine protection against Ebola virus infection
of nonhuman primates. Nat Med 17, 1128-1131.
Tong, Y.G., Shi, W.F., Liu, D., Qian,
J., Liang, L., Bo, X.C., Liu, J., Ren, H.G., Fan, H., Ni, M., Sun, Y.,
Jin, Y., Teng, Y., Li, Z., Kargbo, D., Dafae, F., Kanu, A., Chen, C.C.,
Lan, Z.H., Jiang, H., Luo, Y., Lu, H.J., Zhang, X.G., Yang, F., Hu, Y.,
Cao, Y.X., Deng, Y.Q., Su, H.X., Sun, Y., Liu, W.S., Wang, Z., Wang,
C.Y., Bu, Z.Y., Guo, Z.D., Zhang, L.B., Nie, W.M., Bai, C.Q., Sun, C.H.,
An, X.P., Xu, P.S., Zhang, X.L., Huang, Y., Mi, Z.Q., Yu, D., Yao, H.W.,
Feng, Y., Xia, Z.P., Zheng, X.X., Yang, S.T., Lu, B., Jiang, J.F.,
Kargbo, B., He, F.C., Gao, G.F., Cao, W.C., China Mobile Laboratory
Testing Team in Sierra, L., 2015. Genetic diversity and evolutionary
dynamics of Ebola virus in Sierra Leone. Nature 524, 93-96.
Volchkov, V.E., Volchkova, V.A.,
Slenczka, W., Klenk, H.D., Feldmann, H., 1998. Release of viral
glycoproteins during Ebola virus infection. Virology 245, 110-119.
Yu, D.S., Weng, T.H., Wu, X.X., Wang,
F.X.C., Lu, X.Y., Wu, H.B., Wu, N.P., Li, L.J., Yao, H.P., 2017. The
lifecycle of the Ebola virus in host cells. Oncotarget 8, 55750-55759.
Zhao, G.Y., Du, L.Y., Ma, C.Q., Li,
Y., Li, L., Poon, V.K.M., Wang, L.L., Yu, F., Zheng, B.J., Jiang, S.B.,
Zhou, Y.S., 2013. A safe and convenient pseudovirus-based inhibition
assay to detect neutralizing antibodies and screen for viral entry
inhibitors against the novel human coronavirus MERS-CoV. Virology
Journal 10.
Zheng, X., Wong, G., Zhao, Y., Wang,
H., He, S., Bi, Y., Chen, W., Jin, H., Gai, W., Chu, D., Cao, Z., Wang,
C., Fan, Q., Chi, H., Gao, Y., Wang, T., Feng, N., Yan, F., Huang, G.,
Zheng, Y., Li, N., Li, Y., Qian, J., Zou, Y., Kobinger, G., Gao, G.F.,
Qiu, X., Yang, S., Xia, X., 2016. Treatment with hyperimmune equine
immunoglobulin or immunoglobulin fragments completely protects rodents
from Ebola virus infection. Sci Rep 6, 24179.